Specifically, BRG1 and AP-1 associations have been shown globally at enhancer sites in mouse embryonic fibroblasts (Vierbuchen et al., 2017), mouse mammary epithelial cells (Hu et al., 2011), and described specifically for CCND1 in NSCLC (Xue et al., 2019a) and in AML (Michel et al., 2018). Here, SMARCA4 is linked to acute myeloid leukemia.